ArticleEuropean geriatric medicine2026
Longitudinal trends of percutaneous endoscopic gastrostomy in geriatric hospital units in Germany.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fiberoptic endoscopic evaluation of swallowing in German stroke units: a retrospective diagnosis-related group analysis (2019-2024).Neurological research and practice · 2026Article
- Beyond percutaneous endoscopic gastrostomy: a broader view of nutritional care in older adults.European geriatric medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo quantify long-term trends in percutaneous endoscopic gastrostomy (PEG) use in geriatric inpatient care in Germany and describe associated diagnoses and in-hospital mortality.
methodsWe conducted a nationwide retrospective cohort study using the GEMIDAS Pro registry (2006-2024) and included all patients aged ≥ 60 years. According to the database items, we received information about the incidence of PEG placement, nutrition-relevant diagnoses, patients age, functional and mental status, length of hospital stay, where patients were admitted from and discharged to and the hospital mortality of patients with and without PEG placement.
resultsAmong 1,355,436 admissions (≥ 60 y; mean age 83y; 67% women), 4091 (0.3%) underwent PEG placement. Annual prevalence declined from 1.31% (2006) to 0.07% (2024, p < 0.001), a 94.7% relative reduction (absolute decrease 1.24 percentage points). Binary logistic regression confirmed a 10% per-year reduction in the odds of PEG placement (OR 0.90, 95% CI 0.894-0.905; p < 0.001). Among PEG recipients, stroke was the most frequent nutrition-relevant main diagnosis and dysphagia the most frequent secondary diagnosis. Dementia was the main indication in only 0.8% of PEG recipients, and as a secondary diagnosis it declined from 40% (2006) to 15% (2024, p = 0.021). In-hospital mortality was higher with PEG than without (11% vs 3%, p < 0.001); mortality among PEG recipients decreased with an undulating course over time (24.3% in 2006 to 7.4% in 2024, p < 0.001).
conclusionPEG use in German geriatric units declined substantially during the last two decades. The pattern aligns with a more selective, guideline-concordant practice focused on neurogenic dysphagia, alongside reduced use in dementia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.